TGTX TG Therapeutics, Inc.
$56.44▲ +3.01%
Healthcare
Other
After hours
$57.10▲ +1.17%
Oct 27, 4:47 PM ET
Volume 1.48M
Avg Volume (10D) 1.41M
Key Metrics & Fundamentals
Market Cap
$8.64B
P/E Ratio
20.5
Div Yield
0.00%
52W Range
26.76 - 59.30
% vs 50 MA
2.90%
% vs 200 MA
30.20%
RSI-14
57.2
MACD Histogram
+0.1300
Beta (1Y vs SPY)
0.50
Free Cash Flow
$38.97M
Gross Rev
$240.34M
Gross Profit
$199.14M
EBITDA
$26.90M
COGS
$41.19M
Operating Exp
$177.47M
Operating Income
$21.67M
EBIT
$21.67M
Pretax Income
$10.23M
Net Income
$7.78M
EPS (Diluted)
0.05
Price & Volume History
Loading chart…
Recent News
TG Therapeutics (TGTX) Stock May Be Underpriced Relative To Earnings
Simply Wall St. · Oct 27, 2026 6:12 PM ET
How Investors Are Reacting To TG Therapeutics (TGTX) Early MS Cell Therapy Data
Simply Wall St. · Oct 27, 2026 5:10 PM ET
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions
Zacks · Oct 27, 2026 11:16 AM ET
Mirum Pharmaceuticals, Inc. (MIRM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Oct 27, 2026 9:00 AM ET
Henry Schein to Report Q3 Earnings: Here's What You Should Know
Zacks · Oct 27, 2026 8:21 AM ET
TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data
Zacks · Oct 26, 2026 10:41 AM ET
Incyte & Genmab Collaborate to Develop a New Colorectal Cancer Therapy
Zacks · Oct 26, 2026 10:25 AM ET
RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall
Zacks · Oct 26, 2026 10:17 AM ET
TG Therapeutics (TGTX) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Zacks · Oct 26, 2026 9:00 AM ET
CareDx to Report Q3 Earnings: Transplant Testing Growth in Focus
Zacks · Oct 26, 2026 8:58 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See TGTX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.